The Future of Clinical Trials
Tom Rico Pamukcu

The clinical research methods of yesterday won’t work for the science of tomorrow, yet the field as a whole is slow to adapt. With the end of blockbuster drugs and the rise of personalized medicine, companies and researchers will need to evolve to avoid being left behind. Not only is adapting to change critical for survival, but those that can adapt the fastest will have a tremendous opportunity in the years ahead.

This talk will identify the good, the bad, and the ugly in the current state of clinical trials, and cross-reference it against advancements in adjacent fields. Expect to learn actionable steps to take today to prepare for the clinical research of tomorrow. Building on your existing understanding of clinical research, you’ll receive new insights for how to personally leverage advances and new trends in technology, policy, and funding to better help your patients and your biotech initiatives thrive.

Speaker Bio

Tom Rico Pamukcu is a clinical research expert who has spent the past decade leveraging technology to improve clinical research across academia, industry, and start-ups. He is the founder of a new technology consultancy dedicated to helping researchers modernize clinical trials. Previously, Tom managed global operations for Genentech’s late-stage pediatric oncology pipeline. Before joining Genentech, Tom worked at multiple levels of clinical research at Stanford University. He served as Research Manager for Stanford’s Division of Pain Medicine, and prior to that, managed research at the Sleep Center.

Tom specializes in integrating technology into research, and pioneered some of the first implementations of tools such as EDC, e-Consent, and artificial intelligence into clinical trials across his various institutions. He is currently on the board of the Northern California Chapter of the Association of Clinical Research Professionals. Tom received his BS in Cellular and D